The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study)
Abstract
Current diagnostic studies [radioiodine uptake and serum thyroglobulin (Tg) levels] for residual or metastatic thyroid tissue in patients with differentiated thyroid carcinoma require a hypothyroid status necessary for adequate endogenous TSH stimulation. However, almost all patients have symptoms of clinical hypothyroidism during this period. As shown in the present study, recombinant human TSH (rhTSH) allows stimulation of 131I uptake and Tg release from residual thyroid tissue in euthyroid patients. To assess safety, dosage, and preliminary efficacy, comparison was made of the stimulation of 131I uptake and Tg release after rhTSH administration and after T3 withdrawal in 19 patients after a recent thyroidectomy for differentiated thyroid carcinoma. Various doses (10-40 U) of rhTSH were injected im for 1-3 days in patients receiving suppressive doses of T3. Twenty-four hours after the last dose of rhTSH, 1-2 mCi 131I were administered, followed by a neck and whole body scan 48 h later. After discontinuing T3 for a median period of 19 days (range, 15-28), endogenous serum TSH levels were markedly elevated, and the patients were given a second dose of 131I and rescanned 48 h later. The injections of rhTSH were tolerated well. No major adverse effects were reported; nausea was reported in 3 (16%) and vomiting in 1 of the patients treated with high doses. The quality of life, as measured by two psychometric scales, was far better during rhTSH treatment than after T3 withdrawal. The peak levels of serum TSH (mean +/- SD) after a single dose of 10, 20, or 30 U were 127 +/- 19, 309 +/- 156, and 510 +/- 156 mU/L, respectively, and occurred 2-8 h after injection. Twenty-four hours after the injection, TSH levels decreased to 83 +/- 31, 173 +/- 73, and 463 +/- 148 mU/L in these treatment groups, respectively. The quality of the thyroid scans and the number of sites of abnormal 131I uptake were similar after rhTSH treatment and in the hypothyroid scans in 12 (63%) patients. Two additional sites of uptake in the chest and one in the thyroid bed, not visible on the hypothyroid scans, were identified in 3 (16%) patients after rhTSH. In 1 patient a focus of uptake was better visualized after rhTSH than after withdrawal. In 3 (16%) other patients, 1 lesion in the chest and 2 in the neck were seen only after T3 withdrawal.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS APPLIED TO THE DIAGNOSIS OF HYPOTHYROLDISM
(1969) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067179 · Cited by 183
Influence of Triiodothyronine Withdrawal Time on131I Uptake Postthyroidectomy for Thyroid Cancer
Goldman, J. M., Line, B. R., AAMODT, R. L., & ROBBINS, J. J. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-50-4-734 · Cited by 139
THOTAKURA, N. R., Desai, R. K., Bates, L., Cole, E. S., Pratt, B. M., & Weintraub, B. D. (1991) · Endocrinology · doi:10.1210/endo-128-1-341 · Cited by 135
Schneider, A. B., Line, B. R., Goldman, J. M., & ROBBINS, J. J. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-6-1199 · Cited by 112
Wondisford, F. E., Radovick, S., Moates, J. M., et al. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37788-3 · Cited by 109
Albrecht, R., & Ewing, S. J. (1989) · Journal of Personality Assessment · doi:10.1207/s15327752jpa5301_4 · Cited by 78
Stanley, M. M., & Astwood, E. B. (1949) · Endocrinology · doi:10.1210/endo-44-1-49 · Cited by 74
Saal, W., GLOWANIA, H.-J., Hengst, W., & Happ, J. (1991) · Fertility and Sterility · doi:10.1016/s0015-0282(16)54476-8 · Cited by 70
Hershman, J. M., & EDWARDS, C. L. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-5-814 · Cited by 70
Metabolic Clearance and Production Rates of Human Thyrotropin
Ridgway, E. C., Weintraub, B. D., & Maloof, F. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107630 · Cited by 66
Huber, G. K., Fong, P., Concepcion, E., & Davies, T. F. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-6-1328 · Cited by 50
Standardization of TSH Testing
Taunton, O. D., McDaniel, H. G., & Pittman, J. A. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-2-266 · Cited by 45
Glycosylation and Posttranslational Processing of Thyroid-Stimulating Hormone: Clinical Implications
Weintraub, B. D., STANNARD, B. S., Magner, J. A., Ronin, C., Taylor, T., Joshi, L., Constant, R. B., Menezes‐Ferreira, M. M., Petrick, P. A., & Gesundheit, N. (1985) · Elsevier eBooks · doi:10.1016/b978-0-12-571141-8.50018-4 · Cited by 34
STUDIES ON THE EFFECT OF THYROTROPIN ON HUMAN THYROID FUNCTION*
Einhorn, J., & Larsson, L. (1959) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-19-1-28 · Cited by 26
QUANTITATIVE STUDIES OF IODINE METABOLISM IN IODIDE-TREATED THYROTOXICOSIS.
Harden, R. M., Koutras, D. A., Wd, A., & Wayne, E. J. (1964) · PubMed · Cited by 19
Human Thyrotrophic Hormone Kinetics and Effects in Euthyroid Males
Kuku, S. F., Harsoulis, P., Kjeld, M., & Fraser, T. (1975) · Hormone and Metabolic Research · doi:10.1055/s-0028-1093789 · Cited by 16
Cited by
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Haugen, B. R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P. W., Sherman, S. I., Cooper, D. S., Graham, K. E., Braverman, L. E., Skarulis, M. C., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6094 · Cited by 566
Ladenson, P. W., Braverman, L. E., Mazzaferri, E. L., Brucker-Davis, F., Cooper, D. S., Garber, J. R., Wondisford, F. E., Davies, T. F., DeGroot, L. J., Daniels, G. H., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371304 · Cited by 466
Szkudlinski, M. W., Fremont, V., Ronin, C., & Weintraub, B. D. (2002) · Physiological Reviews · doi:10.1152/physrev.00031.2001 · Cited by 458
Pacini, F., Molinaro, E., Castagna, M. G., Agate, L., Elisei, R., Ceccarelli, C., Lippi, F., Taddei, D., Grasso, L., & Pinchera, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021925 · Cited by 428
Metadata
- Authors
- Meier, C. A.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1994-01-01
- Volume
- 78
- Issue
- 1
- Pages
- 188-196
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2034774830
- Cited by
- 257
- References
- 16
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.